About the Editors

Editors-in-Chief

 

Hillard M. Lazarus, USA

Hillard Lazarus is Professor of Medicine and Director of Novel Cell Therapies at Case Western Reserve University, University Hospitals Case Medical Center, where he is The George & Edith Richman Professor & Distinguished Scientist in Cancer Research. Dr. Lazarus is recognized for his contributions in the areas of mesenchymal stem cell transplantation, autologous blood and marrow transplantation for lymphoma, and allogeneic blood and marrow transplantation for malignancies. He has over 500 publications and has been a committed teacher and mentor to countless house officers, fellows and faculty.

Mohamad Mohty, France

Mohamad Mohty is Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France). Professor Mohty is also head of a translational research team (INSERM) at the Saint-Antoine Research centre in Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of immunomodulatory agents. He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of multiple myeloma. Professor Mohty is currently president of the European Society for Blood and Marrow Transplantation (EBMT). He serves on the board of the EBMT, and the “Intergroupe Francophone du Myelome” (IFM).

Executive Editor

Robert Peter Gale, USA

Deputy Editors

Jane Apperley, UK 

Armand Keating, Canada

Alejandro Madrigal, UK

Yair Reisner, Israel

Associate Editors

Karen Ballen, USA 

A. John Barrett, USA 

Ali Bazarbachi, Lebanon
Ali Bazarbachi, MD, PhD is a Professor of Medicine (Hematology and Oncology), Associate Dean for basic research, and Director of the bone marrow transplantation program at the American University of Beirut-Medical Center in Lebanon. His research focuses on developing oncogene-targeted therapies for adult T cell leukemia/lymphoma and acute myeloid leukemia as well as on post transplant pharmacological interventions. He has co-authored more than 210 articles in leading scientific journals. He is the Chairman of the EMBMT Leukemia Working Party, Chairman of the NCCN Lymphoma Group for Middle East and North Africa, and Associate Editor of Bone Marrow Transplantation.

Ed Copelan, USA

Jan Cornelissen, Netherlands

Marcelo Fernandez-Vina, USA

Sergio Giralt, USA 

Rupert Handgretinger, Germany 

Per Ljungman, Sweden 
Per Ljungman is senior physician at Department of Cellular Therapy and Allogeneic Stem Cell Transplantation at Karolinska University hospital and former director of the departments of hematology and allogeneic stem cell transplantation at the same hospital. He is also former professor (adjunct) of hematology, Karolinska Institutet, Stockholm, Sweden. Per Ljungman was the first chair of the Infectious Diseases Working Party of the EBMT and has also served as the EBMT secretary. He has published more than 350 peer reviewed papers most on viral infections and vaccinations in allogeneic stem cell transplant recipients.

Arnon Nagler, Israel 

Jakob Passweg, Switzerland 

Pavan Reddy, USA

Bipin Savani, USA
Professor of Medicine, Director of Long Term Transplant Clinic and Medical Director of the Stem Cell Transplant Processing Laboratory at Vanderbilt University Medical Center & Veterans Affairs Medical. Dr Savani’s area of specialization is in the treatment of hematological malignancies and stem cell transplantation, and his primary field of research is in the long-term follow-up after transplantation, including regimen-related toxicity/ supportive care, and outcomes analysis of transplant recipients. He has published over 300 peer-reviewed articles, reviews, book chapters, editorials, perspectives and commentaries in the field of hematological malignancies and stem cell transplantation. He is an associate editor of the journals Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation; and serves as an editorial advisory board member for several journals in the field. Dr Savani serves as director of community/ clinical practice and executive board member of American Society of Blood and Marrow Transplantation (ASBMT). 

Takanori Teshima, Japan 

Marcie Riches, USA

Mei-Jie Zhang, USA